E2007
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Refractory Partial Seizures
Conditions
Refractory Partial Seizures
Trial Timeline
Apr 1, 2009 → Nov 1, 2009
NCT ID
NCT00849212About E2007
E2007 is a phase 2 stage product being developed by Eisai for Refractory Partial Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT00849212. Target conditions include Refractory Partial Seizures.
What happened to similar drugs?
3 of 20 similar drugs in Refractory Partial Seizures were approved
Approved (3) Terminated (1) Active (16)
🔄SHR2554; Chidamide analog tablets + SHR2554 analog tablets; ChidamideJiangsu Hengrui MedicinePhase 3
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (10)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03201900 | Phase 3 | Completed |
| NCT02116907 | Phase 1 | Completed |
| NCT00849212 | Phase 2 | Completed |
| NCT00592904 | Phase 2/3 | Completed |
| NCT00451633 | Phase 2 | Withdrawn |
| NCT00427011 | Phase 2 | Terminated |
| NCT00360412 | Phase 3 | Terminated |
| NCT00286897 | Phase 3 | Completed |
| NCT00165789 | Phase 2 | Completed |
| NCT00154063 | Phase 2 | Completed |
Competing Products
20 competing products in Refractory Partial Seizures